Luigi Aurisicchio

4.2k total citations · 1 hit paper
107 papers, 3.0k citations indexed

About

Luigi Aurisicchio is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Luigi Aurisicchio has authored 107 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Immunology, 43 papers in Molecular Biology and 36 papers in Oncology. Recurrent topics in Luigi Aurisicchio's work include Immunotherapy and Immune Responses (46 papers), Virus-based gene therapy research (33 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Luigi Aurisicchio is often cited by papers focused on Immunotherapy and Immune Responses (46 papers), Virus-based gene therapy research (33 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). Luigi Aurisicchio collaborates with scholars based in Italy, United States and Israel. Luigi Aurisicchio's co-authors include Gennaro Ciliberto, Nicola La Monica, Fabio Palombo, Emanuele Marra, Giuseppe Roscilli, Rita Mancini, Andrea Facciabene, Daniela Peruzzi, Rebecca S. Cook and Carlos L. Arteaga and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Luigi Aurisicchio

106 papers receiving 3.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy

2025 25 citations Eleonora Pinto, Lisa A. Lione et al. Journal of Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luigi Aurisicchio Italy	32	1.4k	1.0k	966	585	461	107	3.0k
Tapan K. Bera United States	34	1.5k 1.0×	1.0k 1.0×	1.0k 1.0×	340 0.6×	258 0.6×	87	3.6k
Jonathan Pol France	34	1.2k 0.8×	1.2k 1.2×	1.6k 1.7×	1.1k 1.9×	263 0.6×	80	3.3k
James Barsoum United States	33	2.9k 2.0×	762 0.8×	802 0.8×	1.1k 1.9×	321 0.7×	64	4.2k
Zachary C. Hartman United States	27	1.2k 0.8×	908 0.9×	1.0k 1.1×	549 0.9×	272 0.6×	68	2.5k
Thomas Welte United States	33	1.5k 1.0×	1.5k 1.5×	1.7k 1.8×	451 0.8×	595 1.3×	65	4.0k
Martin Löwer Germany	24	1.9k 1.3×	2.5k 2.5×	1.8k 1.9×	352 0.6×	374 0.8×	44	4.1k
David Escors Spain	43	1.6k 1.1×	2.7k 2.7×	2.4k 2.5×	677 1.2×	292 0.6×	128	5.5k
John C. Castle United States	15	1.2k 0.8×	1.5k 1.5×	1.2k 1.3×	210 0.4×	212 0.5×	21	2.8k
Arthur E. Frankel United States	40	2.6k 1.8×	2.5k 2.5×	1.4k 1.5×	450 0.8×	495 1.1×	144	5.2k
Massimo Spada Italy	32	1.9k 1.3×	1.8k 1.8×	812 0.8×	241 0.4×	761 1.7×	58	4.1k

Countries citing papers authored by Luigi Aurisicchio

Since Specialization

Citations

This map shows the geographic impact of Luigi Aurisicchio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Aurisicchio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Aurisicchio more than expected).

Fields of papers citing papers by Luigi Aurisicchio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luigi Aurisicchio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Aurisicchio. The network helps show where Luigi Aurisicchio may publish in the future.

Co-authorship network of co-authors of Luigi Aurisicchio

This figure shows the co-authorship network connecting the top 25 collaborators of Luigi Aurisicchio. A scholar is included among the top collaborators of Luigi Aurisicchio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luigi Aurisicchio. Luigi Aurisicchio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pinto, Eleonora, Lisa A. Lione, Mirco Compagnone, et al.. (2025). From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy. Journal of Translational Medicine. 23(1). 10–10. 25 indexed citations breakdown →

Aurisicchio, Luigi, Angelo Meduri, Jiří Mosinger, et al.. (2024). Advancing surface safety: the role of sol-gel nanocoatings in the context of MIRIA European project. Journal of Sol-Gel Science and Technology. 112(3). 639–647. 2 indexed citations

Martins, Mathias, Antonella Conforti, Joseph A. Impellizeri, et al.. (2023). A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets. Archives of Virology. 168(4). 124–124. 4 indexed citations

Conforti, Antonella, Mirco Compagnone, James A. Hayward, et al.. (2022). Linear DNA amplicons as a novel cancer vaccine strategy. Journal of Experimental & Clinical Cancer Research. 41(1). 195–195. 11 indexed citations

Ramot, Yuval, Gianfranco Caselli, Luigi Aurisicchio, et al.. (2021). Toxicity and Local Tolerance of COVID- eVax, a Plasmid DNA Vaccine for SARS-CoV-2, Delivered by Electroporation. Toxicologic Pathology. 49(7). 1255–1268. 5 indexed citations

Napoli, Arianna Di, Francesca Ascenzi, Alessandro Gulino, et al.. (2020). IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas. Cancer Immunology Immunotherapy. 70(5). 1379–1392. 18 indexed citations

Thakur, Varsha, Jun Lu, Giuseppe Roscilli, et al.. (2017). The natural compound fucoidan from New Zealand Undaria pinnatifida synergizes with the ERBB inhibitor lapatinib enhancing melanoma growth inhibition. Oncotarget. 8(11). 17887–17896. 29 indexed citations

Lanzardo, Stefania, Laura Conti, Ronald Rooke, et al.. (2015). Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer. Cancer Research. 76(1). 62–72. 103 indexed citations

Aurisicchio, Luigi, Giuseppe Roscilli, Emanuele Marra, et al.. (2015). Superior Immunologic and Therapeutic Efficacy of a Xenogeneic Genetic Cancer Vaccine Targeting Carcinoembryonic Human Antigen. Human Gene Therapy. 26(6). 386–398. 6 indexed citations

10.

Vesci, Loredana, Giuseppe Roscilli, Luigi Aurisicchio, et al.. (2015). Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance. Oncology Reports. 34(3). 1146–1152. 7 indexed citations

11.

Walsh, Alex J., Rebecca S. Cook, Melinda E. Sanders, et al.. (2014). Quantitative Optical Imaging of Primary Tumor Organoid Metabolism Predicts Drug Response in Breast Cancer. Cancer Research. 74(18). 5184–5194. 229 indexed citations

12.

Riccardo, Federica, Luigi Aurisicchio, Joseph A. Impellizeri, & Federica Cavallo. (2014). The importance of comparative oncology in translational medicine. Cancer Immunology Immunotherapy. 64(2). 137–148. 31 indexed citations

13.

Giovanni, Carla De, Giordano Nicoletti, Arianna Palladini, et al.. (2009). A Multi-DNA Preventive Vaccine for p53/Neu-Driven Cancer Syndrome. Human Gene Therapy. 20(5). 453–464. 9 indexed citations

14.

Peruzzi, Daniela, Giuseppe Mesiti, Gennaro Ciliberto, Nicola La Monica, & Luigi Aurisicchio. (2009). Telomerase and HER-2/neu as targets of genetic cancer vaccines in dogs. Vaccine. 28(5). 1201–1208. 36 indexed citations

15.

Aurisicchio, Luigi, Daniela Peruzzi, Antonella Conforti, et al.. (2009). Treatment of Mammary Carcinomas in HER-2 Transgenic Mice through Combination of Genetic Vaccine and an Agonist of Toll-Like Receptor 9. Clinical Cancer Research. 15(5). 1575–1584. 37 indexed citations

16.

Dharmapuri, Sridhar, et al.. (2008). An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models. Cancer Gene Therapy. 16(5). 462–472. 19 indexed citations

17.

Camacho, Ramon E., Richard Wnek, Paul Fischer, et al.. (2007). Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1∗01 transgene: a model of SCID-hu mouse for vaccine development. Experimental Hematology. 35(8). 1219–1230. 11 indexed citations

18.

Peruzzi, Daniela, Agostino Cirillo, Annalisa Meola, et al.. (2006). A chimpanzee serotype-based adenoviral vector as vaccine for CEA. Cancer Research. 66. 330–330. 2 indexed citations

19.

Facciabene, Andrea, Luigi Aurisicchio, & Nicola La Monica. (2004). Baculovirus Vectors Elicit Antigen-Specific Immune Responses in Mice. Journal of Virology. 78(16). 8663–8672. 91 indexed citations

20.

Salucci, Valentina, Mengji Lu, Luigi Aurisicchio, et al.. (2002). Expression of a New Woodchuck IFN- α Gene by a Helper-Dependent Adenoviral Vector in Woodchuck Hepatitis Virus-Infected Primary Hepatocytes. Journal of Interferon & Cytokine Research. 22(10). 1027–1034. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact